Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01)

Post Date

February 14th 2011

Application Due Date

May 7th 2014

Funding Opportunity Number

PA-11-121

CFDA Number(s)

93.839

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $None

Grant Description

is FOA issued by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases encourages applications from institutions/organizations that propose collaborative research projects by multi-disciplinary teams to advance our understanding of molecular and cellular mechanisms underlying ribosomal dysfunction. These research areas include effects on hematopoiesis and their role in bone marrow failure syndromes. Multi-disciplinary expertise across basic and clinical components is encouraged. To meet the objectives of this FOA applicants are encouraged to integrate ribosomal biology with bone marrow failure to develop and characterize models of ribosomopathies.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PA-11-121.html